Paloma Partners’s 9 Meters Biopharma NMTR Stock Holding History

Paloma Partners’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,485	Closed	-$104K	–	2376
2019 Q2	$104K	Buy	+4,485	New	+$135K	﹤0.01%	1622

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paloma Partners's NMTR Position: Q3 2019 in Review

Paloma Partners sold out of 9 Meters Biopharma (NMTR) in Q3 2019, closing a stake of 4,485 shares — an estimated $104K sold.

Paloma Partners first reported a position in NMTR in Q2 2019 and held it in 1 quarter. The position peaked at $104K in Q2 2019. 19 funds tracked by Wall St. Rank hold NMTR as of Q3 2019.

Paloma Partners reported no remaining 9 Meters Biopharma position as of Q3 2019 after selling out during the quarter.
Paloma Partners sold 4,485 9 Meters Biopharma shares in Q3 2019, an estimated $104K.
Paloma Partners first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 1 quarter.
Paloma Partners's 9 Meters Biopharma position peaked at $104K in Q2 2019.
19 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.